Walleye Capital LLC Sells 177,664 Shares of ASP Isotopes Inc. (NASDAQ:ASPI)

Walleye Capital LLC lessened its stake in ASP Isotopes Inc. (NASDAQ:ASPI - Free Report) by 92.2% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 15,000 shares of the company's stock after selling 177,664 shares during the quarter. Walleye Capital LLC's holdings in ASP Isotopes were worth $68,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. Hanson & Doremus Investment Management bought a new stake in shares of ASP Isotopes during the fourth quarter valued at approximately $27,000. B. Riley Wealth Advisors Inc. acquired a new stake in shares of ASP Isotopes in the 3rd quarter valued at $42,000. Avantax Advisory Services Inc. bought a new stake in shares of ASP Isotopes during the fourth quarter worth $45,000. Russell Investments Group Ltd. lifted its stake in shares of ASP Isotopes by 56.3% during the fourth quarter. Russell Investments Group Ltd. now owns 10,221 shares of the company's stock valued at $46,000 after acquiring an additional 3,682 shares during the period. Finally, SVB Wealth LLC bought a new position in ASP Isotopes in the fourth quarter valued at about $49,000. Institutional investors and hedge funds own 16.80% of the company's stock.

ASP Isotopes Trading Up 9.2 %

NASDAQ:ASPI traded up $0.50 on Friday, hitting $5.90. 890,458 shares of the stock were exchanged, compared to its average volume of 2,353,419. The company has a debt-to-equity ratio of 0.80, a quick ratio of 7.54 and a current ratio of 7.55. ASP Isotopes Inc. has a 52 week low of $1.86 and a 52 week high of $9.33. The stock has a market capitalization of $425.06 million, a price-to-earnings ratio of -9.62 and a beta of 3.44. The company's 50-day moving average price is $4.80 and its 200 day moving average price is $5.33.

Insider Transactions at ASP Isotopes

In other ASP Isotopes news, CEO Paul Elliot Mann sold 316,667 shares of the company's stock in a transaction on Tuesday, April 15th. The shares were sold at an average price of $5.75, for a total transaction of $1,820,835.25. Following the completion of the sale, the chief executive officer now owns 7,948,787 shares in the company, valued at approximately $45,705,525.25. The trade was a 3.83 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, COO Robert Ainscow sold 66,666 shares of the firm's stock in a transaction on Tuesday, April 15th. The stock was sold at an average price of $5.75, for a total value of $383,329.50. Following the completion of the transaction, the chief operating officer now owns 1,553,326 shares in the company, valued at $8,931,624.50. This represents a 4.12 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 766,667 shares of company stock worth $4,358,502 in the last quarter. 21.40% of the stock is owned by company insiders.

ASP Isotopes Profile

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.